Breast cancer remains the leading malignancy among women globally, yet AI-based detection systems focus predominantly on mammography while whole-body CT imaging is routinely performed for oncological staging thus, remains critically underexplored. Existing CT-based studies are limited by small datasets, geographical bias, and lack of spatial localization capabilities. This study introduces a radiologist-verified CT scan dataset of 9330 annotated slices from three Pakistani hospitals, approved by institutional ethics committees. Data was partitioned into training (70%), validation (15%), and test (15%) sets to develop a two-stage deep learning framework. The training data includes 6,106 whole-body CT slices (3,053 tumor, 3,053 normal). The perfectly balanced training dataset eliminates class-level imbalance, while detection-level imbalance is addressed through distributional focal loss mechanisms. We systematically evaluated seven transfer learning architectures (VGG16, VGG19, ResNet50V2, InceptionV3, DenseNet121, DenseNet201, EfficientNetB0–B5), revealing that VGG16 achieved optimal performance (82% accuracy, 0.80 AUC-ROC) compared to deeper architectures (ResNet50V2: 49%, EfficientNet: 50%), demonstrating that simpler models exhibit better inductive bias for constrained medical imaging datasets. Building upon this, we developed an integrated YOLOv11-Seg framework exploiting architectural innovations: C3K2 bottleneck modules for hierarchical feature extraction, Spatial Pyramid Pooling Fast (SPPF) for multi-scale context aggregation, and Pixel Spatial Attention (C2PSA) for enhanced boundary delineation. YOLOv11-Seg achieved 84.6% precision, 90% recall, 0.84 mAP@50, 0.839 Dice coefficient, and 0.724 mean IoU. Error analysis revealed false negatives (3.83%) primarily from low-contrast lesions and small tumors (10,000 frames demonstrated 10 FPS processing, 93.1% sensitivity, 97.9% specificity, and 94.3% temporal consistency, enabling clinical workflow integration. Limitations of the current study include single-radiologist annotation, geographical homogeneity, retrospective design, and binary classification scope, warranting prospective multi-center validation, multi-class classification extension, and explainable AI development. This work establishes foundation for AI-assisted opportunistic breast cancer screening in whole-body CT imaging, particularly valuable for resource-constrained settings, with clear pathways toward comprehensive staging and diagnostic support systems.